Dissociation of thyrotropin receptor function and thyrotropin dependency in rat thyroid tumour cell lines derived from FRTL-5.

[1]  J. Parma,et al.  Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. , 1995, The New England journal of medicine.

[2]  J. Mockel,et al.  Relative contribution of phosphoinositides and phosphatidylcholine hydrolysis to the actions of carbamylcholine, thyrotropin, and phorbol esters on dog thyroid slices: regulation of cytidine monophosphate-phosphatidic acid accumulation and phospholipase-D activity. II. Actions of phorbol esters. , 1994, Endocrinology.

[3]  M. Saji,et al.  Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. , 1994, Molecular endocrinology.

[4]  A. Pinchera,et al.  Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  A. Saiardi,et al.  Thyroid transcription factor 1 activates the promoter of the thyrotropin receptor gene. , 1993, Molecular endocrinology.

[6]  J. Parma,et al.  Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas , 1993, Nature.

[7]  J. Shiloach,et al.  Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. , 1993, Endocrinology.

[8]  T. Sano,et al.  Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Mutation detection by polymerase chain reaction—primer‐introduced restriction analysis , 1993, Cancer.

[9]  E. Friedman,et al.  The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the alpha-subunit of Gs in human thyroid neoplasms. , 1993, The Journal of clinical endocrinology and metabolism.

[10]  S. Nagataki,et al.  Overexpression of the intact thyrotropin receptor in a human thyroid carcinoma cell line. , 1993, Endocrinology.

[11]  M. Zannini,et al.  Multiple mechanisms of interference between transformation and differentiation in thyroid cells , 1992, Molecular and cellular biology.

[12]  R. Lauro,et al.  Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters , 1992, Molecular and cellular biology.

[13]  J. Parma,et al.  The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.

[14]  M. Blankenstein,et al.  A Method for Measuring the Binding Affinity and Capacity of Growth Hormone Binding Protein in Human Serum Using FPLC to Separate Bound and Free Ligand , 1992 .

[15]  J. Fujimoto,et al.  Protein kinase-C activation during thyrotropin-stimulated proliferation of rat FRTL-5 thyroid cells. , 1992, Endocrinology.

[16]  B. Rapoport,et al.  The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning. , 1992, Molecular endocrinology.

[17]  M. Parmentier,et al.  Thyroid adenocarcinomas secondary to tissue-specific expression of simian virus-40 large T-antigen in transgenic mice. , 1991, Endocrinology.

[18]  P. Rocmans,et al.  Unlike thyrotropin, thyroid-stimulating antibodies do not activate phospholipase C in human thyroid slices. , 1991, The Journal of clinical investigation.

[19]  T. Endo,et al.  The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. , 1991, Biochemical and biophysical research communications.

[20]  A. Fusco,et al.  Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expression. , 1990, Biochemical and biophysical research communications.

[21]  B. Rapoport,et al.  The functional expression of recombinant human thyrotropin receptors in nonthyroidal eukaryotic cells provides evidence that homologous desensitization to thyrotropin stimulation requires a cell-specific factor. , 1990, Endocrinology.

[22]  E. Kawasaki,et al.  Two G protein oncogenes in human endocrine tumors. , 1990, Science.

[23]  J. van den Brink,et al.  Thyrotropin dependent and independent thyroid cell lines selected from FRTL-5 derived tumors grown in nude mice. , 1990, Endocrinology.

[24]  J. Dumont,et al.  Regulation of protooncogenes c-fos and c-myc expressions by protein tyrosine kinase, protein kinase C, and cyclic AMP mitogenic pathways in dog primary thyrocytes: a positive and negative control by cyclic AMP on c-myc expression. , 1990, Experimental cell research.

[25]  M. Parmentier,et al.  Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies. , 1989, Biochemical and biophysical research communications.

[26]  F. Wyllie,et al.  Structure and expression of nuclear oncogenes in multi-stage thyroid tumorigenesis. , 1989, British Journal of Cancer.

[27]  J. Jauniaux,et al.  The cyclic AMP-mediated stimulation of cell proliferation. , 1989, Trends in biochemical sciences.

[28]  F. Hornicek,et al.  Evidence that adenosine 3',5'-monophosphate mediates stimulation of thyroid growth in FRTL5 cells. , 1986, Endocrinology.

[29]  G. Colletta,et al.  Induction of the c-fos oncogene by thyrotropic hormone in rat thyroid cells in culture. , 1986, Science.

[30]  S H Ingbar,et al.  Properties and regulation of the thyrotropin receptor in the FRTL5 rat thyroid cell line. , 1986, Endocrinology.

[31]  A. Moses,et al.  Thyrotropin and dibutyryl cyclic AMP increase levels of c-myc and c-fos mRNAs in cultured rat thyroid cells. , 1986, The Journal of biological chemistry.

[32]  H. Coon,et al.  Culture of hormone-dependent functional epithelial cells from rat thyroids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[33]  F. Karlsson,et al.  Human Thyrotropin Receptors are Expressed Independently of the State of Thyroid Hormone Production in Thyroid Tissue , 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[34]  B. Westermark,et al.  Thyrotropin is not a growth factor for human thyroid cells in culture. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[35]  K. Burton.  A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. , 1956, The Biochemical journal.

[36]  G. Milligan,et al.  Inverse agonism: pharmacological curiosity or potential therapeutic strategy? , 1995, Trends in pharmacological sciences.

[37]  M. Parmentier,et al.  Function, proliferation and differentiation of the dog and human thyrocyte. , 1990, Hormone and metabolic research. Supplement series.

[38]  E. J. V. van Zoelen.  Receptor-ligand interaction: a new method for determining binding parameters without a priori assumptions on non-specific binding. , 1989, The Biochemical journal.

[39]  M. Homma,et al.  Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma. , 1981, The Journal of clinical endocrinology and metabolism.

[40]  笠木 寛治.  Adenylate cyclase activity in thyroid tissue from patients with untreated Graves' disease , 1980 .

[41]  K. Christov,et al.  Experimental thyroid carcinogenesis. , 1972, Current topics in pathology. Ergebnisse der Pathologie.

[42]  S. H. Wollman.  PRODUCTION AND PROPERTIES OF TRANSPLANTABLE TUMORS OF THE THYROID GLAND IN THE FISCHER RAT. , 1963, Recent progress in hormone research.